NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT04720417 2025-07-15Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal MelanomaThomas Jefferson UniversityPhase 2 Terminated13 enrolled 13 charts